resveratrol has been researched along with Condition, Preneoplastic in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WW; Chang, YC; Hsieh, YC; Huang, YH; Kuo, YL; Lin, CW; Wang, BY; Yu, CC | 1 |
| Chumanevich, A; Cui, X; Habiger, J; Hofseth, AB; Hofseth, LJ; Jin, Y; Nagarkatti, M; Nagarkatti, PS; Pena, E; Poudyal, D; Singh, UP | 1 |
| Birt, DF; Brummer, EC; Kineman, BD; Paiva, NL | 1 |
| Barnes, KF; Bhatia, D; Bishayee, A; Carroll, RT; Darvesh, AS | 1 |
| Alfaras, I; Juan, ME; Planas, JM | 2 |
| Boghossian, S; Hawash, A | 1 |
| Bian, Z; Gou, X; Jia, W; Kou, F; Liao, W; Qiu, Y; Wang, X; Wei, H; Wu, J; Wu, T; Xie, G; Zhang, X; Zhang, Y; Zhou, M | 1 |
| Breinholt, VM; Daneshvar, B; Dragsted, LO; Mølck, AM; Poulsen, M; Svendsen, GW; Vinggaard, AM | 1 |
| Nalini, N; Sengottuvelan, M; Senthilkumar, R | 1 |
| Nalini, N; Sengottuvelan, M | 1 |
| Au, A; Birt, DF; Brummer, EC; Kaiser, MS; Kineman, BD; Paiva, NL | 1 |
| Beecher, CW; Cai, L; Farnsworth, NR; Fong, HH; Jang, M; Kinghorn, AD; Mehta, RG; Moon, RC; Pezzuto, JM; Slowing, KV; Thomas, CF; Udeani, GO | 1 |
| Caderni, G; Davit, A; Sarotto, I; Tessitore, L | 1 |
2 review(s) available for resveratrol and Condition, Preneoplastic
| Article | Year |
|---|---|
Chemoprevention in colorectal cancer--where we stand and what we have learned from twenty year's experience.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Anticarcinogenic Agents; Colorectal Neoplasms; Histone Deacetylase Inhibitors; Humans; Metformin; Precancerous Conditions; Resveratrol; Selective Estrogen Receptor Modulators; Stilbenes | 2012 |
Colorectal cancer chemoprevention by trans-resveratrol.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Disease Models, Animal; Genetic Predisposition to Disease; Humans; Precancerous Conditions; Resveratrol; Stilbenes | 2012 |
12 other study(ies) available for resveratrol and Condition, Preneoplastic
| Article | Year |
|---|---|
Resveratrol suppresses myofibroblast activity of human buccal mucosal fibroblasts through the epigenetic inhibition of ZEB1 expression.
Topics: Enhancer of Zeste Homolog 2 Protein; Epigenomics; Fibroblasts; Humans; Mouth Mucosa; Mouth Neoplasms; Myofibroblasts; Oral Submucous Fibrosis; Precancerous Conditions; Resveratrol; Stilbenes; Zinc Finger E-box-Binding Homeobox 1 | 2016 |
Resveratrol suppresses colitis and colon cancer associated with colitis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinogens; Cell Separation; Colitis; Colonic Neoplasms; Female; Flow Cytometry; Immunohistochemistry; Inflammation; Male; Mice; Mice, Inbred C57BL; Precancerous Conditions; Resveratrol; Stilbenes; T-Lymphocytes | 2010 |
Resveratrol from transgenic alfalfa for prevention of aberrant crypt foci in mice.
Topics: Animals; Azoxymethane; Body Weight; Chromatography, High Pressure Liquid; Colonic Neoplasms; Eating; Female; Glucosides; Lactase-Phlorizin Hydrolase; Medicago sativa; Mice; Plants, Genetically Modified; Precancerous Conditions; Resveratrol; Stilbenes | 2010 |
Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis.
Topics: Animals; Antioxidants; Carcinogens; Chemical and Drug Induced Liver Injury; Diethylnitrosamine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Induction; Female; Hyperplasia; Inflammation; Lipid Peroxidation; Liver; Liver Neoplasms, Experimental; NF-E2-Related Factor 2; Nitric Oxide Synthase Type II; Oxidative Stress; Phenobarbital; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes; Tyrosine | 2010 |
trans-Resveratrol reduces precancerous colonic lesions in dimethylhydrazine-treated rats.
Topics: 1,2-Dimethylhydrazine; Animals; Colon; Colonic Neoplasms; Disease Models, Animal; Humans; Male; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2010 |
Metabonomic variations associated with AOM-induced precancerous colorectal lesions and resveratrol treatment.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Colorectal Neoplasms; Male; Metabolome; Precancerous Conditions; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2012 |
Effects of dietary antioxidants and 2-amino-3-methylimidazo[4,5-f]- quinoline (IQ) on preneoplastic lesions and on oxidative damage, hormonal status, and detoxification capacity in the rat.
Topics: Animals; Antioxidants; Biomarkers; Carotenoids; Colon; Comet Assay; Diet; Glutathione Transferase; Hormones; Immunohistochemistry; Liver; Lycopene; Male; Oxidation-Reduction; Oxidative Stress; Placenta; Precancerous Conditions; Quercetin; Quinolines; Rats; Rats, Inbred F344; Resveratrol; Stilbenes | 2003 |
Modulatory influence of dietary resveratrol during different phases of 1,2-dimethylhydrazine induced mucosal lipid-peroxidation, antioxidant status and aberrant crypt foci development in rat colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Antioxidants; Catalase; Diet; Glutathione; Intestinal Neoplasms; Lipid Peroxidation; Male; Precancerous Conditions; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase | 2006 |
Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development.
Topics: 1,2-Dimethylhydrazine; Animals; Antineoplastic Agents, Phytogenic; Bacteria; Carcinogens; Colon; Colonic Neoplasms; Dietary Supplements; Disease Models, Animal; Feces; Glycoside Hydrolases; Intestinal Mucosa; Male; Nitroreductases; Polysaccharide-Lyases; Precancerous Conditions; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sulfatases | 2006 |
Transgenic alfalfa that accumulates piceid (trans-resveratrol-3-O-beta-D-glucopyranoside) requires the presence of beta-glucosidase to inhibit the formation of aberrant crypt foci in the colon of CF-1 mice.
Topics: Acyltransferases; Animals; beta-Glucosidase; Colonic Neoplasms; Disease Models, Animal; Female; Glucosides; Humans; Medicago sativa; Mice; Mice, Inbred Strains; Plants, Genetically Modified; Precancerous Conditions; Random Allocation; Resveratrol; Stilbenes | 2007 |
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antimutagenic Agents; Carcinogens; Cell Differentiation; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Female; Fruit; Humans; Inflammation; Isoenzymes; Mammary Neoplasms, Experimental; Membrane Proteins; Mice; Neoplasms, Experimental; Peroxidases; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Resveratrol; Skin Neoplasms; Stilbenes; Tumor Cells, Cultured | 1997 |
Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Azoxymethane; bcl-2-Associated X Protein; Carcinogens; Cell Division; Colon; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Growth Inhibitors; Intestinal Mucosa; Male; Precancerous Conditions; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred F344; Rectum; Resveratrol; Stilbenes | 2000 |